BioCentury is hosting inovios next confernce on april 5th Bio century owns Science-Business eXchange, this division of the company is a joint publishing venture with Nature Publishing Group. Nature publishing group has featured inovio five different times previously. NPG is a monthly peer-reviewed medical journal publishing. Dr Kim has said many times HIV data will be published in a peer-reviewed medical journal. All the dots connect for this conference to be a pivitol catalyst. Also according to I.R. has confirmed Hep C chronvac data is still on track for 1st qtr release which leaves us with 14 days till that catalyst. Patience is the name of the game with Bio techs I have learned this the hard way in one of my previous biotech investments. Im looking foward to Inovio further validating its approach to treatment and this should serve the stock in the eyes of larger investors on the sidelines.
The HIV article should be in the Biotech Scientific Journal coming out in the April Issue. Possible internet "teaser" article prior to publication. Interesting times coming soon....As Dr. Kim said. Thanks Kyle for this info.